Qu, L., Xu, J., Dai, Z., Elyamine, A
In the initial study, equal proportions of participants were assigned to peptide and placebo conditions over a ten day period
Regular monitoring of lipid panels, hemoglobin A1c, blood pressure, and renal function is appropriate for patients on GLP-1 therapy
This encompasses collagen induction, promotion of wound healing, antioxidant effects, inhibition of inflammatory cytokines, and promotion of skin repair
Changing one without professional guidance can lead to either subtherapeutic levels (wasting medication and money) or supratherapeutic levels (unnecessary side effects and potential complications)